Tapper (foot) reported via his personal Twitter account that he's received medical clearance to return to the field.
Tapper underwent surgery to repair a foot he fractured in Week 2. Although the Oklahoma product has played in just two out of a possible 32 games since being drafted in the fourth round of the 2016 draft, Tapper has shown promise when healthy and could be an integral part of the Cowboys' defensive line rotation in 2018.
Tapper (foot) has been given an updated recovery timetable of 8-10 weeks, Brandon George of The Dallas Morning News reports.
Tapper was originally given a timetable for 10-12 weeks, but with the potential to now return a couple weeks sooner, the defensive end could could end up being activated off injured reserve later in the season. David Irving, who is returning from a four-game suspension, is expected to take on the roster spot left open by Tapper's absence.
Tapper will undergo surgery on his broken foot later this week and is expected to be out 10-12 weeks, The Dallas Morning News reports.
While this is yet another setback for the 2016 fourth-round pick, the timing is nearly perfect for the Cowboys, who can free up a roster spot for the returning David Irving (suspension) by placing Tapper on IR. The defensive end from Oklahoma still has the physical tools to make an impact at some point, but Tapper will have to wait until next season to try and prove he can stay healthy and contribute to the Dallas pass rush.
It's a tough blow for Tapper after missing the entirety of his rookie season with a back injury in 2016. The 24-year-old was a healthy scratch each of the last two weeks and is now looking at a more prolonged absence, but a specific timetable has yet to be announced.
Tapper was recently limited by a neck injury, which does not appear to be slowing him down anymore. He was hindered by a hip injury earlier in camp as well. Both injuries may have played a role in his inconsistency at camp thus far. The rookie is looking to make an impression and earn a role on the defensive line.